Pharmaceutical
Learn about the latest developments in the pharmaceutical cannabis industry with Business of Cannabis. Discover new drugs, research, and more.
Pharmaceutical · page 7
- Cultivation
Flora Growth partners with Colombia’s largest indigenous tribe in joint cannabis venture
“We are honoured to be given the opportunity to work hand-in-hand with the Misak people,” said Luis Merchan, Flora’s Chairman and CEO.
- CBD Market
Anti-drug coalition funded by Purdue Pharma opposes the CAOA
LETTER WRITING CAMPAIGN Anti-drug coalition funded by Purdue Pharma opposes the CAOA The Community Anti-Drug Coalitions of America (CADCA) is asking supporters to write to Senators to oppose the recently introduced Cannabis Administration and Opportunity Act on the basis that the legislation doesn’t cap THC levels on products or require packaging to include warning labels,…
- Pharmaceutical
Linneo Health expands medical cannabis offering
The company’s offering will now include cannabis derivatives.
- CBD Market
Brittney Griner’s lawyers argue cannabis was prescribed
ON THE DEFENSE Brittney Griner’s lawyers argue cannabis was prescribed WNBA star Brittney Griner’s lawyer argued that in addition to mistakenly bringing a cannabis vape to Russia while packing in a rush, the cannabis product was prescribed for medical purposes, reports the Guardian.
- Pharmaceutical
OCT Says Potential ‘Mergers & Acquisitions Are On The Table’ As It Prepares For Vital Upcoming Fundraise
OXFORD Cannabinoid Technologies (OCT) is gearing up to raise its second major round of funding since it listed on the London Stock Exchange (LSE) last May.
- Pharmaceutical
European Cannabis Stocks Review: IM Cannabis Could Be Delisted From NASDAQ, DeepVerge Jumps 40%, & More From OCT & Ananda Developments
IM Cannabis IM Cannabis announced to investors earlier this week that on Wednesday, July 13, it was warned its stocks could soon be removed from the NASDAQ stock exchange unless its stock price rises above $1.
- Pharmaceutical
Agreement to carry out Phase 1 cannabinoid medicine clinical trials
Oxford Cannabinoid Technologies Holdings (OCTP) has entered into a master service agreement and work order with Simbec Research Limited.
- Pharmaceutical
Curaleaf’s relationship to Russia under scrutiny
RUSSIAN TIES Curaleaf’s relationship to Russia under scrutiny Chairman Boris Jordan was quick to label the rumours that New Jersey-based MSO Curaleaf was going to be sanctioned after Russia invaded Ukraine “misinformation.”
- Pharmaceutical
Celadon Pharma Says It Wants To Deliver Its ‘Trial And Product As A Holistic Package’ Overseas Amid First Update Since AIM Listing
Celadon Pharmaceuticals recently released its first substantial business update since becoming the first British cannabis company since GW Pharmaceuticals to list on the Alternative Investments Market (AIM) in March this year.
- Hemp Industry
US House pass SAFE Banking reform (again)
BACK IN THE HOUSE US House pass SAFE Banking reform (again) The US House has once again passed SAFE Banking reform, this time as an amendment to the 2023 National Defense Authorization Act (NDAA), per NORML.
- Cultivation
Pennsylvania Governor signs state cannabis banking bill
STATE BANKING Pennsylvania Governor signs state cannabis banking bill Gov.
- CBD Market
European CBD Applications Will Require ‘Complicated And Huge’ Human Studies, Admit EFSA
FOLLOWING the European Food Safety Authority’s (EFSA) controversial decision to ‘stop the clock’ on all CBD novel food applications last month, the regulator addressed the industry in a virtual public forum last week.
